Skip to main content
. Author manuscript; available in PMC: 2019 Sep 4.
Published in final edited form as: Differentiation. 2018 Sep 4;103:24–45. doi: 10.1016/j.diff.2018.08.005

Figure 20.

Figure 20.

Xenograft of a 12-week human fetal female urethra grown for 8 weeks in a castrated DHT-treated host (A-C) immunostained for KRT19, KRT7 and TP63 as indicated. Xenografts of a 13-week human fetal female urethra grown for 8 weeks in a castrated DHT-treated host (D-F) immunostained for KRT19, KRT7 and TP63 as indicated. Arrows in (C)) depict pockets of TP63-negative epithelial cells in areas of incipient canalization.